FDA as­sem­bles ad­comm to re­view GSK's Jem­per­li tri­al plans in rec­tal can­cer

The FDA’s On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee will meet this Thurs­day to dis­cuss whether pro­posed stud­ies would sup­port an ac­cel­er­at­ed ap­proval for GSK’s Jem­per­li in rec­tal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER